Alx Oncology Holdings Inc [NASDAQ: ALXO] surged by $0.27 during the normal trading session on while it closed the day at $1.31.
Alx Oncology Holdings Inc stock has also gained 22.43% of its value over the past 7 days. However, ALXO stock has declined by -21.08% in the 3 months of the year. Over the past six months meanwhile, it has lost -38.79% and lost -21.56% year-on date.
The market cap for ALXO stock reached $69.09 million, with 52.74 million shares outstanding and 33.63 million shares in the current float. Compared to the average trading volume of 1.03M shares, ALXO reached a trading volume of 13633232 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Alx Oncology Holdings Inc [ALXO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ALXO shares is $4.44 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ALXO stock is a recommendation set at 1.33. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Jefferies have made an estimate for Alx Oncology Holdings Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on Mar-07-25. While these analysts kept the previous recommendation, Jefferies raised their target price from $12 to $2. The new note on the price target was released on December 19, 2024, representing the official price target for Alx Oncology Holdings Inc stock. Previously, the target price had yet another raise from $10 to $14, while Stifel kept a Hold rating on ALXO stock. On December 08, 2023, analysts increased their price target for ALXO shares from 8 to 18.
The Average True Range (ATR) for Alx Oncology Holdings Inc is set at 0.13 The Price to Book ratio for the last quarter was 0.51, with the Price to Cash per share for the same quarter was set at 2.82.
ALXO stock trade performance evaluation
Alx Oncology Holdings Inc [ALXO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 22.43. With this latest performance, ALXO shares gained by 1.55% in over the last four-week period, additionally sinking by -38.79% over the last 6 months – not to mention a drop of -91.09% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ALXO stock in for the last two-week period is set at 56.72, with the RSI for the last a single of trading hit 66.47, and the three-weeks RSI is set at 51.71 for Alx Oncology Holdings Inc [ALXO]. The present Moving Average for the last 50 days of trading for this stock 1.4119, while it was recorded at 1.0960 for the last single week of trading, and 3.3486 for the last 200 days.
Alx Oncology Holdings Inc [ALXO]: An insightful look at the core fundamentals
Alx Oncology Holdings Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.82 and a Current Ratio set at 4.82.
Earnings per share (EPS) analysis for Alx Oncology Holdings Inc [ALXO] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ALXO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Alx Oncology Holdings Inc go to 18.87%.
Alx Oncology Holdings Inc [ALXO]: Institutional Ownership
The top three institutional holders of ALXO stocks are: VENBIO PARTNERS LLC with ownership of 9.7 million shares, which is approximately 18.7145%. FMR LLC, holding 7.81 million shares of the stock with an approximate value of $$47.12 million in ALXO stocks shares; and FMR LLC, currently with $$25.45 million in ALXO stock with ownership which is approximately 8.1419%.
